Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Assunto principal
Intervalo de ano de publicação
1.
Int J Gen Med ; 16: 4931-4942, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37928952

RESUMO

Background: Abdominal organ sonography is a crucial part of the workup for treating sickle cell disease (SCD) patients. Objective: The main objective of this study was to evaluate the abdominal organs in SCD patients using ultrasonography. Methodology: A non-interventional descriptive cross-sectional study was carried out in Asir region Saudi Arabia from April 2019 to July 2020. The study was conducted in 78 patients with sickle cell disease (SCD). Data were gathered using a data collection sheet included demographic information, clinical information including medication types, and complications linked to SCD. Furthermore, the study evaluated abdominal ultrasound findings pertaining to the liver, gall bladder, spleen, and kidneys. The data were analyzed using Statistical Package for Social Sciences (SPSS). Results: More than half of the study participants 43 (55.1%) were females. About 53.8% of the study participants received blood transfusions, and (11.5%) receive extra-vaccine. Concerning ultrasound findings, hepatomegaly was found in seventeen (21.8%), focal liver lesions in four (5.1%), gallstones in five (6.4%), splenomegaly in fifteen (19.3%), and the presence of splenic focal lesions was found in seven (9.0%). The most frequent complication associated with SCD was osteomyelitis sepsis in six cases (7.7%). The study revealed a significant correlation between the type of crisis and type of medication used and the size of the spleen (P-value <0.01), and no notable correlation was found between the types of crises and the size of the liver (P-value >0.05). Conclusion: Abdominal sonography in SCD patients revealed a wide range of alterations in the liver, gallbladder, and spleen. The most frequently observed complications in SCD were hepatomegaly, splenomegaly, localized lesions in both organs, and the presence of gallstones.

2.
Curr Med Imaging ; 18(6): 593-603, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34620067

RESUMO

Lung Ultrasound (LUS) has evolved considerably over the last few years. The aim of the current review is to conduct a systematic review reported from a number of studies to show the usefulness of (LUS) and point of care ultrasound for diagnosing COVID-19. A systematic search of electronic data was conducted, including the national library of medicine, and the national institute of medicine, PubMed Central (PMC), to identify the articles published on (LUS) to monitor COVID-19. This review highlights the ultrasound findings reported in articles before the occurrence of the pandemic (11), clinical articles before COVID-19 (14), review studies during the pandemic (27), clinical cases during the pandemic (5) and other varying aims articles. The reviewed studies revealed that ultrasound findings can be used to help in the detection and staging of the disease. The common patterns observed included irregular and thickened A-lines, multiple B-lines ranging from focal to diffuse interstitial consolidation, and pleural effusion. Sub-plural consolidation is found to be associated with the progression of the disease and its complications. Pneumothorax was not recorded for COVID-19 patients. Further improvement in the diagnostic performance of (LUS) for COVID-19 patients can be achieved by using elastography, contrast-enhanced ultrasound, and power Doppler imaging.


Assuntos
COVID-19 , Humanos , Pulmão/diagnóstico por imagem , Pandemias , SARS-CoV-2 , Ultrassonografia/métodos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA